MB-7

N/A

Report date: 2024/05/21 14:15:38

Base Information

Drug NameMB-7
Drug Alias NameMB-7MB7
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionTumor-associated antigen modulatorsInterleukin-2 modulatorsProgrammed cell death protein 1 modulators
TargetsTumor-associated antigenInterleukin-2Programmed cell death protein 1
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMUSTBIO Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesMUSTBIO Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A